Brinsupri (Brensocatib)

Brensocatib is a medicine for bronchiectasis, a lung disease where the airways are widened and keep getting infected and inflamed. It is taken as a pill once a day. It works by calming certain white blood cells so they do less damage to the airways.

Brand names:Brinsupri
Medication

What people taking Brinsupri (Brensocatib) report

Every report comes from a Lived member, sent anonymously.

Have you tried Brinsupri (Brensocatib) for Bronchiectasis?

NameHow it went

About Brinsupri (Brensocatib)

What It's For

Brensocatib, sold as Brinsupri, is a daily tablet for non-cystic fibrosis bronchiectasis in adults and children 12 and older. Bronchiectasis is a long-term lung condition in which the airways become widened and scarred. Mucus collects in them, infections take hold more easily, and many people go through repeated flare-ups: periods of worse cough, more or thicker sputum, breathlessness and tiredness that often need a course of antibiotics. The "non-cystic fibrosis" label matters because bronchiectasis caused by cystic fibrosis is managed differently, and brensocatib is not approved for it. Brensocatib was approved in the US in 2025. It was studied in people who had already had repeated flare-ups, and its main purpose is to make those flare-ups less frequent. It is added to the usual care for bronchiectasis, such as airway clearance techniques and treating infections, rather than replacing it. It has not been studied enough in children under 12 to know whether it is safe and effective for them.

How It Works

In bronchiectasis, the immune system keeps sending white blood cells called neutrophils into the airways. Neutrophils carry enzymes that break down bacteria, but in large amounts these enzymes also damage the airway lining, which keeps the cycle of inflammation, mucus and infection going. Those enzymes are switched on while neutrophils are still maturing in the bone marrow, by another enzyme called DPP1 (dipeptidyl peptidase 1). Brensocatib blocks DPP1, so new neutrophils reach the lungs carrying less active damaging enzyme. It does not kill bacteria and does not open the airways the way an inhaler does. It is meant to be taken every day to keep this inflammation lower over the long term.

Dosage & Administration

Brinsupri comes as 10 mg and 25 mg tablets. Either strength is taken once a day, with or without food; the prescriber chooses which one. Both doses reduced flare-ups to a similar degree in the main study. If you miss a dose, skip it and take the next one at your usual time the next day. Do not take two doses to make up for the missed one.

Side Effects

The side effects reported most often in studies were colds and other upper respiratory infections, headache, rash, dry skin or chapped lips, and high blood pressure. Some of these were also common in people taking a placebo, so not every symptom is caused by the medicine. Skin changes are a recognized effect of brensocatib. Besides rash and dryness, some people develop thickened, rough skin, often on the palms or soles (hyperkeratosis). Tell the care team about any new rash or skin change; they may refer you to a dermatologist. Skin cancers were reported a little more often with the 25 mg dose than with placebo in the main trial. The numbers were small, but it is a reason to have new or changing skin spots checked. Gum and other periodontal problems, such as inflamed or bleeding gums, were also more common, affecting about 1 in 10 people in one study compared with about 1 in 40 on placebo. Brushing, flossing and regular dental checkups are recommended while taking it. Mild hair thinning and small rises in liver blood tests were seen in a few people.

Interactions & Warnings

Avoid live vaccines while taking brensocatib. Live vaccines contain a weakened but living form of a germ, and it is not known how brensocatib affects their safety or how well they work. The warning applies to live vaccines specifically, so ask which of your planned vaccines are live, and tell whoever is giving a vaccine that you take brensocatib. There is no information about brensocatib in pregnancy or breastfeeding. Very high doses caused a bone malformation in rat studies, but that does not show whether it is harmful in people. Anyone pregnant, planning pregnancy or breastfeeding should talk this through with the prescriber. As with any new medicine, give the prescriber and pharmacist a full list of other prescriptions, over-the-counter medicines and supplements.

What to Expect

Brensocatib is a long-term preventive medicine. You should not expect to feel different from day to day; its benefit shows up as fewer flare-ups over months. In the main one-year study, people taking it averaged about one flare-up a year, compared with about 1.3 on placebo, a reduction of roughly one fifth. About half of those taking brensocatib went the whole year without a flare-up, compared with about 4 in 10 on placebo. The 25 mg dose also slowed the gradual loss of lung function a little, while the 10 mg dose did not clearly do so. The study did not show a clear reduction in the most severe flare-ups, those needing hospital care or intravenous antibiotics. Flare-ups can still happen, so airway clearance, other prescribed treatments and the usual plan for treating infections continue. Follow-up visits are a chance to compare your flare-up count with the year before, check your skin and blood pressure, and decide with the care team whether the medicine is worth continuing. Keep up dental visits while you take it.

Questions to Ask Your Doctor

  1. 1.How often have my flare-ups happened, and how much difference would brensocatib be likely to make for me?
  2. 2.Should I take the 10 mg or 25 mg dose, and why?
  3. 3.How will we judge after several months whether it is working well enough to continue?
  4. 4.Which of my vaccines are live vaccines, and should I get any of them before starting?
  5. 5.What skin or gum changes should I report, and should I see a dermatologist or dentist regularly?

Last reviewed • Oct 2026

Educational content, not medical advice.